more NCD deaths in sub-Saharan Africa over two decades highlight critical gaps in diagnosis and care. Our biomarker services make early detection and personalized treatments possible through innovative diagnostics that create regional access for Pharma and biotech to advance global health equity.
Our team specializes in discovering and validating crucial biomarkers for patient stratification. We provide various services that encompass the entire spectrum of biomarker applications, from consultancy and study design to full research and development.
We collaborate closely with clients to develop custom biomarker assays tailored to their specific research needs.
Comprehensive analysis of the entire genome to identify potential genetic markers. Our genomic biomarker services enable personalized treatment plans.
Biomarker support throughout the clinical trial process, from early-stage discovery to late-stage validation. Our services ensure that biomarkers are effectively integrated into trial designs.
We support the development and validation of companion diagnostics that align with specific therapeutic agents.
Our state-of-the-art facilities provide comprehensive biorepository services to manage biospecimens for future research and diagnostics.
We secure IRB approvals before initiating any studies and ensure our biomarker assays meet rigorous ethical and clinical research requirements. Our expertise in sub-Saharan Africa helps us navigate regulatory requirements efficiently and accelerates study timelines.
Our team of experts works meticulously to develop biomarker assays and ensure they meet the highest standards of performance.
High-quality collection and processing according to IRB-approved protocols. Our state-of-the-art biobanking facilities allow for long-term storage and easy retrieval of samples.
Utilizing advanced bioinformatics tools, we analyze complex datasets to extract meaningful insights. Our comprehensive reports provide actionable data that can be used to inform inclusive clinical decisions.